Towa Pharmaceutical Co (JP:4553) has released an update.
Don't Miss Our New Year's Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Towa Pharmaceutical Co., Ltd. has reached a settlement in a patent infringement lawsuit filed by Eagle Pharmaceuticals, Inc. and SymBio Pharmaceuticals Limited concerning two of its intravenous infusion products. The lawsuit, initiated in December 2022, has been resolved with undisclosed terms, and Towa Pharmaceutical will continue to manufacture and sell the products with minimal impact on its consolidated financial results.
For further insights into JP:4553 stock, check out TipRanks’ Stock Analysis page.
